Citeline places biopharma and medical device professionals, and those who focus on these industries, at the forefront of knowledge and insight, by providing the perfect combination of news and information together with penetrating insight and analysis. Citeline is a leader in the field of healthcare industry information.
Publishes | Daily | Episodes | 526 | Founded | 11 years ago |
---|---|---|---|---|---|
Number of Listeners | Category | Business |
Pink Sheet Executive Editor Derrick Gingery, Senior Writer Sarah Karlin-Smith and Editor-in-Chief Nielsen Hobbs discuss the reasons US Food and Drug Administration Commissioner Martin Makary could have helped negotiate the Most Favored Nation drug pr... more
Adalvo: Exploring European B2B Pharma’s Next Steps by Citeline
Join host David Wild as he speaks with Stacie Bell, chief clinical research officer at Lupus Therapeutics, about the dramatic transformation happening in lupus drug development. From a field once avoided by pharma companies to one generating unpreced... more
Listen now: Adalvo – advancing pharma with private equity and an asset-light model
People also subscribe to these shows.
The guy needs to stop saying "um" and "uh" so much between his thoughts.
Can you please send your reporters to Toastmasters so they can focus on removing all the filler words Ahs and Hums form there speech! I can hardly listen to the episodes as one of your reporting says more filler words than real content.
Too many “uh” and broken sentences. I find it so painful to follow
Loved the Mithra episode - could be made better if audio quality was higher.
Often times a podcast with very good information, but quite poorly delivered. As someone who regularly conducts market research interviews via telephone and web, I’m very familiar with reading through far too many colloquialisms, filler words, and trite expressions. Words and phrases such as “right “and you know” “um” “and” “uh” make it painful to listen to in any regular basis.
Key themes from listener reviews, highlighting what works and what could be improved about the show.
How this podcast ranks in the Apple Podcasts, Spotify and YouTube charts.
Apple Podcasts | #218 |
Recent interactions between the hosts and their guests.
Listeners, social reach, demographics and more for this podcast.
Listeners per Episode | |
---|---|
Gender Skew | |
Location | |
Interests | |
Professions | |
Age Range | |
Household Income | |
Social Media Reach |
This podcast offers in-depth exploration into the biopharmaceutical and medical device industries, providing listeners with insights on current news, regulatory changes, and market trends. Topics frequently covered include drug development processes, healthcare policies, and innovations in pharmaceuticals, with a strong emphasis on the implications of these developments for industry professionals. Guests often include prominent figures such as CEOs and experts, who share valuable perspectives that inform the ongoing discussions about the evolving landscape of healthcare and biopharma.
Noteworthy is the podcast's commitment to transparency and accessibility, highlighting unique challenges and changing dynamics within the industry. Its focus... more
Rephonic provides a wide range of podcast stats for Citeline Podcasts. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to Citeline Podcasts and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.
Rephonic provides a full set of podcast information for three million podcasts, including the number of listeners. View further listenership figures for Citeline Podcasts, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.
Rephonic provides comprehensive predictive audience data for Citeline Podcasts, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.
To see how many followers or subscribers Citeline Podcasts has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.
These podcasts share a similar audience with Citeline Podcasts:
1. BioCentury This Week
2. Biotech Hangout
3. The Readout Loud
4. Dwarkesh Podcast
5. All-In with Chamath, Jason, Sacks & Friedberg
Citeline Podcasts launched 11 years ago and published 526 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.
Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.
Rephonic pulls ratings and reviews for Citeline Podcasts from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.
View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.
Rephonic provides full transcripts for episodes of Citeline Podcasts. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.
Recent guests on Citeline Podcasts include:
1. Matt Simmons
2. Dr. Annette Bakker
3. Bola Akinlade
4. Elizabeth Laws
5. Niraj Sharma
6. Scott Schliebner
7. Renita Hite
8. Emre Ozcan
To view more recent guests and their details, simply upgrade your Rephonic account. You'll also get access to a typical guest profile to help you decide if the show is worth pitching.